Human papillomavirus prophylactic vaccine
نویسندگان
چکیده
منابع مشابه
Prophylactic human papillomavirus vaccines.
Human papillomavirus (HPV) infection causes virtually all cases of cervical cancer, the second most common cause of death from cancer among women worldwide. This Review examines prophylactic HPV subunit vaccines based on the ability of the viral L1 capsid protein to form virus-like particles (VLPs) that induce high levels of neutralizing antibodies. Following preclinical research by laboratorie...
متن کاملQuadrivalent human papillomavirus vaccine.
The lifetime risk of human papillomavirus (HPV) infection exceeds 50%. HPV infection causes >550,000 cases of cervical and anogenital cancer worldwide annually. Infection also causes precancerous lesions and genital warts. HPV types 16 and 18 cause approximately 70% of HPV-related cancers, and HPV types 6 and 11 cause approximately 90% of cases of genital warts. A quadrivalent vaccine for HPV t...
متن کاملA Long Way: History of the Prophylactic Papillomavirus Vaccine
For more than one and a half centuries, papillomaviruses have been recognized as causative agents for benign and malignant disease in humans as well as in a number of animal species [43]. It took more than five decades to provide sufficient evidence for the general acceptance of HPV as necessary cause for the development of anogenital cancer in humans. At the end of this long road of extensive ...
متن کاملHuman papillomavirus vaccine and pregnancy.
UNLABELLED QUESTION A: patient of mine who recently learned she was 6 weeks pregnant had received the recombinant human papillomavirus (HPV) quadrivalent vaccine at 4 weeks of gestation. She is quite worried about how this will affect her baby. What is known about the safety of the HPV vaccine during pregnancy? ANSWER The HPV vaccine is generally not recommended for use in pregnant women. How...
متن کاملProphylactic and therapeutic human papillomavirus vaccine: a breakthrough for women health.
Human Papilloma Virus (HPV) associated cervical cancer is amongst the ten most common cancers in women in the developing world. New vaccines markedly reduce the economic burden of diseases on a country's health system. Two types of HPV vaccines are available; prophylactic and therapeutic. Prophylactic vaccines target (Late protein) L1 and to a lesser extent L2, which stimulate neutralizing anti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Uirusu
سال: 2012
ISSN: 0042-6857
DOI: 10.2222/jsv.62.79